GLP-1 and Liver Enzymes: What ALT and AST Mean

If your liver enzymes changed after starting a GLP-1, the expected direction is down, not up. ALT and AST usually fall on these medications, and in the largest trial to look at it properly they fell substantially. That runs against the instinct most people have when a lab value moves while they are on a new drug, so it is worth understanding what these numbers are actually telling you.

What ALT and AST actually measure

ALT (alanine aminotransferase) and AST (aspartate aminotransferase) are enzymes that live inside liver cells. When liver cells are inflamed or damaged, some of their contents leak into the bloodstream, and a blood test picks that up. Higher numbers mean more leakage.

Two things follow that are easy to miss. They measure injury, not function: a liver can be scarred and still show near-normal enzymes. And ALT is fairly specific to the liver while AST also comes from muscle, so AST can rise after hard exercise without the liver being involved at all.

Why yours were probably raised before you started

This is the part that reframes the question. Mildly elevated ALT and AST are extremely common in people who go on to be prescribed a GLP-1, and the usual reason is metabolic dysfunction-associated steatotic liver disease: fat accumulating in the liver, driven by insulin resistance and excess weight.

Most people who have it do not know. It produces no symptoms for years, and the first sign is often exactly this: a slightly high ALT on routine bloods that nobody explains. If your enzymes were already elevated when you started, the medication did not cause that. The condition that led to the prescription did. We cover the disease itself in GLP-1 and fatty liver.

What happens to them on a GLP-1

The ESSENCE trial gives the clearest answer available. It enrolled adults with biopsy-confirmed MASH and moderate fibrosis, randomised them to semaglutide 2.4 mg or placebo, and published 72-week results in the New England Journal of Medicine.

The liver enzymes moved consistently and substantially:

• ALT fell by roughly 40 per cent relative to placebo
• AST fell by roughly 30 per cent relative to placebo
• GGT, another marker of liver stress, improved as well

Those are placebo-adjusted figures, which matters: they are the effect attributable to the drug, not the effect of being in a trial and paying more attention to your health.

The trial also hit its harder endpoints. More participants achieved resolution of steatohepatitis without worsening fibrosis, and more achieved at least a one-stage improvement in fibrosis, than on placebo. Falling enzymes were not an isolated number moving; the tissue underneath was changing too.

Is it just the weight loss?

Partly, and that would be a perfectly good reason on its own. Losing weight reduces liver fat, and reduced liver fat means less inflammation and lower enzymes.

But the analyses suggest the liver benefit is not entirely explained by weight change, which points to effects on insulin sensitivity and inflammation that run somewhat independently of the number on the scale. This remains an area where the mechanism is less settled than the outcome. The enzymes fall; exactly how much of that is weight and how much is something else is still being worked out.

What the MASH approval does and does not mean

On 15 August 2025, the FDA approved Wegovy (semaglutide 2.4 mg) for adults with noncirrhotic MASH and moderate to advanced liver fibrosis. It was the first GLP-1 to receive a liver indication.

Four qualifications matter, and they are routinely dropped in coverage of this:

• It is Wegovy, not Ozempic. Same molecule, different product and different label. Ozempic does not carry a MASH indication.
• It is an accelerated approval, granted on part of the trial. Confirmatory evidence is still being collected, and accelerated approvals can be modified if it does not hold.
• Noncirrhotic only, with moderate to advanced fibrosis. It is not an approval for fatty liver in general, and not for cirrhosis.
• It does not mean you should ask for it because your ALT is 45. The indication rests on biopsy-confirmed disease with staged fibrosis, which is a long way from a mildly abnormal blood test.

When rising enzymes are worth taking seriously

Everything above describes the usual pattern. It is not a promise, and a rise deserves an explanation rather than reassurance.

GLP-1 receptor agonists are not known to be hepatotoxic, so when enzymes climb on one, the more likely culprits are elsewhere:

• Alcohol, which is the first thing any clinician will ask about, and where an AST higher than ALT is a recognised pattern
• Other medications and supplements, including over-the-counter ones. Paracetamol, some antibiotics, and a number of bodybuilding and herbal supplements are well-documented causes
• Very rapid weight loss, which can transiently raise enzymes even while the long-run direction is downward
• Gallbladder disease, which is more common during rapid weight loss and can raise liver enzymes along with bilirubin
• Viral hepatitis or an autoimmune cause that was there all along and has never been tested for

Contact your prescriber promptly rather than waiting for the next routine check if a rise comes with yellowing of the skin or eyes, dark urine, pale stools, persistent right-upper-abdominal pain, or unusual bruising. Those change the urgency.

What to actually ask for

If you are starting a GLP-1 or already on one and want your liver tracked sensibly:

• Get a baseline. Enzymes are far more informative as a trend than as a single value, and without a starting point you cannot tell a fall from a normal result.
• Ask what the trend is doing, not just whether today's number is flagged. A drop from 78 to 52 is good news even though 52 is still outside the reference range.
• Mention alcohol and supplements honestly. Both change the interpretation, and neither is what your clinician is judging you for.
• Ask whether imaging is warranted if enzymes stay elevated. Blood tests cannot stage fibrosis, and a FibroScan or similar answers a question ALT never will.

This article is educational and is not medical advice. Liver test results only mean something in the context of your full history, other medications, alcohol intake, and previous results, and interpreting them is a job for a clinician who has all of that. Never start, stop, or change a prescription on the basis of a single blood test.